Axa’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-242,100
| Closed | -$646K | – | 1130 |
|
|
2022
Q1 | $646K | Sell |
242,100
-8,800
| -4% | -$23.5K | ﹤0.01% | 1010 |
|
|
2021
Q4 | $1.09M | Buy |
250,900
+19,300
| +8% | +$83.5K | ﹤0.01% | 939 |
|
|
2021
Q3 | $1.18M | Buy |
+231,600
| New | +$1.18M | ﹤0.01% | 947 |
|
|
2021
Q1 | – | Sell |
-239,650
| Closed | -$1.57M | – | 1235 |
|
|
2020
Q4 | $1.57M | Buy |
239,650
+78,524
| +49% | +$514K | ﹤0.01% | 902 |
|
|
2020
Q3 | $1.07M | Buy |
161,126
+72,600
| +82% | +$483K | ﹤0.01% | 930 |
|
|
2020
Q2 | $737K | Buy |
+88,526
| New | +$737K | ﹤0.01% | 1000 |
|